Skip to main content
ETON logo

ETON · Eton Pharmaceuticals, Inc. · Debt

Track ETON — free
$50.72 -0.23 (-0.45%) Play latest call Q2 2026 earnings call transcript
Market Cap
$1.46B
Shares
28.58M
Volume · Nov 4 375.17K Avg daily vol (3M) 561.49K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current debt and lease obligations 2026-06-30 USD 8,825,000 10-Q filed 2026-08-13
Finance lease liabilities 2026-06-30 USD 0 10-Q filed 2026-08-13
Noncurrent debt carrying amount 2026-06-30 USD 19,078,000 10-Q filed 2026-08-13
Operating lease liabilities 2026-06-30 USD 1,322,000 10-Q filed 2026-08-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 239,000
Noncurrent operating lease liabilities
USD 1,083,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1710340 CUSIP 29772L108 13F (30d) 59 filings 59 filers Visit website Investor relations